Oklahoma House Bill HB2280

Oklahoma 2024 Regular Session

• Introduced: 2/6/23
• Refer: 2/7/23

Caption

Public health and safety; increasing registration fee for certain registrants; emergency.

Impact

By implementing these fee increases, HB 2280 may significantly influence the cost structure for medical professionals and facilities. Practitioners, who currently pay $140, will see their annual fees become more substantial, while manufacturers will experience a rise from $500 to $2,500 annually. This could have a cascading impact on healthcare delivery, potentially leading to increased costs for patients as facilities may pass on these regulatory costs to consumers.

Summary

House Bill 2280 proposes amendments to the Uniform Controlled Dangerous Substances Act, specifically targeting the registration processes and fees for entities involved in the handling of controlled substances. The bill seeks to increase the registration fees across various categories, including practitioners, medical facility owners, distributors, and manufacturers. This adjustment in fees aims to enhance state regulatory capabilities concerning the safety and handling of controlled substances in Oklahoma.

Contention

The bill's passage may face opposition from various stakeholders, particularly those concerned with the increased financial burden on medical practitioners and small businesses operating in the healthcare domain. Advocates for reduced regulation might argue that the increased fees could limit access to necessary medical care and services due to financial constraints faced by smaller entities. Additionally, the exclusions of certain registrants from presumed qualification under this legislation could create further debate around accessibility and public health outcomes in Oklahoma.